Evidence map›Paper›PMID 28467514›Full record

ArticlePloS one2017

A plasma mir-125a-5p as a novel biomarker for Kawasaki disease and induces apoptosis in HUVECs.

Zhuoying Li, Jie Jiang, Lang Tian, Xin Li, Jia Chen, Shentang Li, Chunyun Li, Zuocheng Yang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Epigenetics in Kawasaki Disease.Frontiers in pediatrics · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. The regulatory role of microRNAs in angiogenesis-related diseases.Journal of cellular and molecular medicine · 2018
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zhuoying LiDepartment of Pediatrics, The Third Xiangya Hosptial of Central South University, Changsha, Hunan, P.R.China.ORCID http://orcid.org/0000-0002-2193-537X
Jie JiangDepartment of Pediatrics, The Third Xiangya Hosptial of Central South University, Changsha, Hunan, P.R.China.
Lang TianDepartment of Pediatrics, The Third Xiangya Hosptial of Central South University, Changsha, Hunan, P.R.China.
Xin LiDepartment of Pediatrics, The Third Xiangya Hosptial of Central South University, Changsha, Hunan, P.R.China.
Jia ChenDepartment of Pediatrics, The Third Xiangya Hosptial of Central South University, Changsha, Hunan, P.R.China.
Shentang LiDepartment of Pediatrics, The Third Xiangya Hosptial of Central South University, Changsha, Hunan, P.R.China.
Chunyun LiDepartment of Pediatrics, The Third Xiangya Hosptial of Central South University, Changsha, Hunan, P.R.China.
Zuocheng YangDepartment of Pediatrics, The Third Xiangya Hosptial of Central South University, Changsha, Hunan, P.R.China.
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKawasaki disease (KD) is a childhood systemic vasculitis that exhibits a specific preference for the coronary arteries. The aetiology remains unknown and there are no especially diagnostic tests. microRNAs (miRNAs) are 18 to 23 nucleotides non-coding RNAs that are negative regulator of gene expression and play a crucial role in the regulatory network of the genome. Recently, circulating miRNAs have been found presentation in human plasma and displayed some characteristics of the ideal biomarker. However, few researches explored differentially expressed miRNAs in the plasma of KD patients. Our study is to identify circulating miRNAs in KD plasma which can serve as potential biomarkers of KD diagnosis. MATERIALS AND

methodsThe total of five pairs of acute KD and normal plasma samples were analyzed using ABI miRNAs TLDA Assay chip. Differentially expression of miR-125a-5p in plasma were confirmed by quantitative real-time PCR (qRT-PCR) in independent cohort (acute KD = 30, convalescent KD = 30 and healthy control = 32). After bioinformatics prediction, miR-125a-5p vector and inhibitor were transfected into HUVECs respectively, to observe MKK7 expression as a potential target gene. Flow cytometry was used to analyze apoptosis. The mRNA and protein levels of desired genes including MKK7, Caspase-3, Bax and Bcl2 were detected by qRT-PCR and western blotting.

resultsEighteen miRNAs were differentially expressed in acute KD's plasma compared with healthy control. miR-125a-5p was significantly increased in plasma of KD patients (p = 0.000), but no variation between acute and convalescent KD (p = 0.357). Moreover, the results from the gain and loss functions of miR-125a-5p in HUVECs have shown that miR-125a-5p remarkably suppressed MKK7 expression, as a novel target gene. Importantly, miR-125a-5p also induced apoptosis in HUVECs through inhibition MKK7 levels to regulate Bax/Bcl2 pathway resulting to activate Caspase-3.

conclusionOur study indicated that the circulating miR-125a-5p levels in KD's plasma have remarkably evaluated compared with healthy individuals. miR-125a-5p might play a role in the development of KD by regulating target gene MKK7 to induce apoptosis in vascular endothelial cells. Therefore, our findings have suggested that detected miR-125a-5p levels in plasma could be used as a potential biomarker in early KD diagnosis.

Indexed as

ApoptosisBiomarkersHumansHuman Umbilical Vein Endothelial CellsMicroRNAsMucocutaneous Lymph Node SyndromeBiomarkersMicroRNAsMIRN125 microRNA, human

Identifiers

PMID28467514
PMCPMC5415180
OpenAlexW2611217613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.